Tuberculosis: Annual update

被引:12
作者
Duncan, K
机构
[1] Glaxo Wellcome Research/Development, Medicines Research Centre, Stevenage, Hertfordshire SG1 2NY, Gunnels Wood Road
关键词
D O I
10.1517/13543776.7.2.129
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
More people died from tuberculosis (TB) in 1995 than in any other year in history; a depressing statistic considering that agents with potent antimycobacterial activity have been widely available for over 40 years. Factors such as the human immunodeficiency virus (HIV) pandemic and the emergence of multi-drug resistant strains of Mycobacterium tuberculosis contribute to the ever-increasing number of TB sufferers worldwide. Progress is being made in the development of tools with which to analyse and manipulate the genome of M. tuberculosis, in the search for novel TB drugs and in identifying vaccine candidates. Of particular significance has been the successful application of relatively new techniques utilising naked DNA vaccination to provide protection against M. tuberculosis infection.
引用
收藏
页码:129 / 137
页数:9
相关论文
共 102 条
  • [21] CRYSTAL-STRUCTURE AND FUNCTION OF THE ISONIAZID TARGET OF MYCOBACTERIUM-TUBERCULOSIS
    DESSEN, A
    QUEMARD, A
    BLANCHARD, JS
    JACOBS, WR
    SACCHETTINI, JC
    [J]. SCIENCE, 1995, 267 (5204) : 1638 - 1641
  • [22] Tuberculosis: Current status and recent developments in diagnostics, drugs and vaccines
    Duncan, K
    [J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 1996, 6 (02) : 175 - 185
  • [23] TUMOR-NECROSIS-FACTOR-ALPHA IS REQUIRED IN THE PROTECTIVE IMMUNE-RESPONSE AGAINST MYCOBACTERIUM-TUBERCULOSIS IN MICE
    FLYNN, JL
    GOLDSTEIN, MM
    CHAN, J
    TRIEBOLD, KJ
    PFEFFER, K
    LOWENSTEIN, CJ
    SCHREIBER, R
    MAK, TW
    BLOOM, BR
    [J]. IMMUNITY, 1995, 2 (06) : 561 - 572
  • [24] Construction by homologous recombination and phenotypic characterization of a DNA polymerase domain polA mutant of Mycobacterium smegmatis
    Gordhan, BG
    Andersen, SJ
    DeMeyer, AR
    Mizrahi, V
    [J]. GENE, 1996, 178 (1-2) : 125 - 130
  • [25] GRANGE JM, 1996, MYCOBACTERIA HUMAN D
  • [26] Auxotrophic vaccines for tuberculosis
    Guleria, I
    Teitelbaum, R
    McAdam, RA
    Kalpana, G
    Jacobs, WR
    Bloom, BR
    [J]. NATURE MEDICINE, 1996, 2 (03) : 334 - 337
  • [27] IMPLICATIONS OF MULTIDRUG-RESISTANCE FOR THE FUTURE OF SHORT-COURSE CHEMOTHERAPY OF TUBERCULOSIS - A MOLECULAR STUDY
    HEYM, B
    HONORE, N
    TRUFFOTPERNOT, C
    BANERJEE, A
    SCHURRA, C
    JACOBS, WR
    VANEMBDEN, JD
    GROSSET, JH
    COLE, ST
    [J]. LANCET, 1994, 344 (8918) : 293 - 298
  • [28] PROTECTION AGAINST MALARIA BY IMMUNIZATION WITH A PLASMODIUM-YOELII CIRCUMSPOROZOITE PROTEIN NUCLEIC-ACID VACCINE
    HOFFMAN, SL
    SEDEGAH, M
    HEDSTROM, RC
    [J]. VACCINE, 1994, 12 (16) : 1529 - 1533
  • [29] GENE REPLACEMENT AND EXPRESSION OF FOREIGN DNA IN MYCOBACTERIA
    HUSSON, RN
    JAMES, BE
    YOUNG, RA
    [J]. JOURNAL OF BACTERIOLOGY, 1990, 172 (02) : 519 - 524
  • [30] Immunogenicity and protective efficacy of a tuberculosis DNA vaccine
    Huygen, K
    Content, J
    Denis, O
    Montgomery, DL
    Yawman, AM
    Deck, RR
    DeWitt, CM
    Orme, IM
    Baldwin, S
    DSouza, C
    Drowart, A
    Lozes, E
    Vandenbussche, P
    VanVooren, JP
    Liu, MA
    Ulmer, JB
    [J]. NATURE MEDICINE, 1996, 2 (08) : 893 - 898